AKAN

AkandaC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

AKAN vs peer average

63/100

AKAN vs. peer average (C vs. D)

Grade spread

B 2 · C 1 · D 4 · F 3

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

QNRX is the first available peer comparator.

Loose same-sector and same-size comparator only; not a direct operating peer because Akanda's current disclosed drivers are Nasdaq compliance, cannabis operations, and a fiber subsidiary rather than a clear single-asset biotech program.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerQNRXQuoin

AKAN

Akanda

QNRX

Quoin

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs QNRX

AKAN / QNRX

Grade Position

In line

AKAN vs. peer average (C vs. D)

63/100

Momentum

AKAN

Value

QNRX

Sentiment

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs AKAN

QNRX

60/100

Even

APRE

20/100

CVKD

20/100

CNSP

CNS Pharmaceuticals Inc Common

20/100

ERNA

Ernexa Therapeutics Inc Common

40/100

QNRX is the first peer returned for this comparison set.